The use of dye surrogates to illustrate local anesthetic drug sequestration by lipid emulsion: A visual demonstration of the lipid sink effect

Regional Anesthesia and Pain Medicine

Volumn 37, Issue 2, 2012, Pages 183-187

  Papadopoulou, Aikaterini ^a   Willers, Johann W ^a   Samuels, Theophilus L ^a   Uncles, David R ^a  

^a WORTHING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; DYE; HEPARIN; INTRALIPID; LIDOCAINE; LIPID EMULSION; LOCAL ANESTHETIC AGENT;

ARTICLE; CARDIOTOXICITY; FLOCCULATION; HYPOTHESIS; LIPOPHILICITY; LOCAL ANESTHESIA; NEUROTOXICITY; PRIORITY JOURNAL; SUPERNATANT;

ANESTHETICS, LOCAL; ANTHRAQUINONES; CHEMISTRY, PHARMACEUTICAL; COLOR; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMULSIONS; LIPIDS; ROSANILINE DYES;

EID: 84859760295     PISSN: 10987339     EISSN: 15328651     Source Type: Journal    
DOI: 10.1097/AAP.0b013e318244b2b7     Document Type: Article

References (31)

1. Weinberg GL. Treatment of local anesthetic systemic toxicity (LAST). Reg Anesth Pain Med. 2010;35:188Y193.
2. Cave G, Harvey M, Graudins A. Intravenous lipid emulsion as antidote: a summary of published human experience. Emerg Med Australas. 2011;23:123Y141.
3. Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anesthetic toxicity: a systematic review. Acad Emerg Med. 2009;16:815Y824.
4. Association of Anaesthetists of Great Britain and Ireland. Guidelines for the Management of Severe Local Anaesthetic Toxicity. Available at: www.aagbi.org/publications/publications-guidelines/M/R . Accessed July 30, 2011.
5. American College of Medical Toxicology. ACMT position statement: interim guidance for the use of lipid resuscitation therapy. J Med Toxicol. 2011;7:81Y82.
6. Neal JM, Bernards CM, Butterworth JF 4th, et al. ASRA practice advisory on local anesthetic systemic toxicity. Reg Anesth Pain Med. 2010;35:152Y161.
7. Samuels TL, Willers JW, Uncles DR, Monteiro R, Halloran C, Dai H. In vitro suppression of drug-induced methaemoglobin formation by Intralipid(\) in whole human blood: observations relevant to the lipid sink theory.' Anaesthesia. 2012;67:23Y32.
8. French D, Smollin C, Ruan W, Wong A, Drasner K, Wu AH. Partition constant and volume of distribution as predictors of clinical efficacy of lipid rescue for toxicological emergencies. Clin Toxicol (Phila). 2011;49:801Y809.
9. Krieglstein J, Meffert A, Niemeyer DH. Influence of emulsified fat on chlorpromazine availability in rabbit blood. Experientia. 1974;30:924Y926.
10. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia Amaro MF, Cwik MJ. Pretreatment or resuscitation with a lipid infusion shifts the dose-response to bupivacaine-induced asystole in rats. Anesthesiology. 1998;88:1071Y1075. (Pubitemid 28193335)
11. Mazoit JX, Le Guen R, Beloeil H, Benhamou D. Binding of long-lasting local anesthetics to lipid emulsions. Anesthesiology. 2009;110:380Y386.
12. Weinberg G, Lin B, Zheng S, et al. Partitioning effect in lipid resuscitation: further evidence for the lipid sink. Crit Care Med. 2010;38:2268Y2269.
13. Weinberg GL, Palmer JW, VadeBoncouer TR, Zuechner MB, Edelman G, Hoppel CL. Bupivacaine inhibits acylcarnitine exchange in cardiac mitochondria. Anesthesiology. 2000;92:523Y528. (Pubitemid 30078352)
14. Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci U S A. 1992;89:6452Y6456.
15. Watt P, Malik D, Dyson L. Gift of the globVis it foolproof? Anaesthesia. 2009;64:1031Y1033.
16. Dimeski G. A commentary on the effect of lipid emulsions on pathology tests. Anaesthesia. 2009;64:1033Y1035.
17. Laine J, Lokajová J, Parshintsev J, Holopainen JM, Wiedmer SK. Interaction of a commercial lipid dispersion and local anesthetics in human plasma: implications for drug trapping by "lipid-sinks". Anal Bioanal Chem. 2010;396:2599Y2607.
18. Waring MJ. Lipophilicity in drug discovery. Expert Opin Drug Discov. 2010;5:235Y248.
19. Roscoe SB, Rakow NA, Husberg ML, Mcintosh LH III. Screening method of formulating a pharmaceutical composition by using model compounds. 3M Innovative Properties Company, WO/2005/036165. Available at: www.sumobrain.com/patents/ WO2005036165.html . Accessed July 30, 2011.
20. ChemSpider Database. Available at: www.chemspider.com/RecordView.aspx? rid=3877d0b1-ccac-41a7-9fef-3d2955f2bf4c . Accessed July 30, 2011.
21. ChemSpider Database. Available at: www.chemspider.com/RecordView.aspx? rid=4961a37a-60bd-4847-94a4-a6c96bb75f57 . Accessed July 30, 2011.
22. Huang YF, Pryor ME, Mather LE, Veering BT. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth Analg. 1998;86:797Y804. (Pubitemid 28177735)
23. Tucker GT. Pharmacokinetics of local anaesthetics. Br J Anaesth. 1986;58:717Y731. (Pubitemid 16098076)
24. Willers J, Uncles DR, Samuels TL, Papadopoulou A, Short S. In vitro separation of Intralipid emulsion into lipid rich supernatant and a lipid poor sediment by addition of heparin: a potential method of determining the effect of Intralipid administration on lipophilic free drug concentrations: 9AP8-2 [abstract]. Eur J Anaesthesiol. 2011;28:145Y146.
25. LeVeen HH, Giordano P, Johnson A. Flocculation of intravenous fat emulsions. Am J Clin Nutr. 1965;16:129Y134.
26. Di Ninni P, Martelli F, Zaccanti G. Effect of dependent scattering on the optical properties of Intralipid tissue phantoms. Biomed Opt Express. 2011;2:2265Y2278.
27. Zausig YA, Graf BM, Zink W. Is it "lipid sink," haemodilution, or both? Crit Care Med. 2009;37:2863.
28. Nancarrow C, Rutten AJ, Runciman WB, et al. Myocardial and cerebral drug concentrations and the mechanisms of death after fatal intravenous doses of lidocaine, bupivacaine, and ropivacaine in the sheep. Anesth Analg. 1989;69:276Y283. (Pubitemid 20033447)
29. Rutten AJ, Nancarrow C, Mather LE, Ilsley AH, Runciman WB, Upton RN. Hemodynamic and central nervous system effects of intravenous bolus doses of lidocaine, bupivacaine, and ropivacaine in sheep. Anesth Analg. 1989;69:291Y299. (Pubitemid 20033449)
30. French D, Armenian P, Ruan W, et al. Serum verapamil concentrations before and after Intralipid\ therapy during treatment of an overdose. Clin Toxicol. 2011;49:340Y344.
31. Weinberg GL, Ripper R, Murphy P, et al. Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med. 2006;31:296Y303. (Pubitemid 44062378)